LENSAR, Inc. (LNSR:NASDAQ) closed at $5.81 on October 20, 2026, up 1.04% on the day. The stock trades 55.1% below its 52-week high of $12.94 and 17.4% above its 52-week low of $4.95. Over the past year, it lost 53.2%. LENSAR, Inc. is part of the Health Care sector.
In 252 trading sessions since October 20, 2025, LNSR closed higher on 117 days (46%). Its best day was August 13, 2026 (+31.48%) and its worst was March 17, 2026 (-32.85%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
Find more stocks like LNSR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.